[Ip-health] Chalkidou on NICE and Health Impact Fund

[Aidan Hollis]

Kalipso Chalkidou has written a fascinating paper on lessons from the
experience of NICE for the Health Impact Fund (and, by extension, for
other prize-type systems in which rewards are paid based on assessed
health impact).

Assessing the Added Value of Health Technologies: NICE=92s Experience in
England
Kalipso Chalkidou
Visiting Faculty, Berman Institute for Bioethics, Johns Hopkins
University, Baltimore, MD; NICE International,
National Institute for Health and Clinical Excellence, UK
kalipso.chalkidou@nice.org.uk

Abstract: This paper reviews the role and functions of the National
Institute for Health and Clinical Excellence (NICE) in the context of
assessing the Health Impact Fund (HIF). It highlights areas in which
NICE=92s experiences are relevant to the HIF. NICE has been an
important, transformational organization, and its ten-year history
offers many lessons for the HIF.

The paper is available at
http://www.yale.edu/macmillan/igh/discussion_papers.html

This discussion paper provides both some background on NICE as well as
suggesting challenges for implementation of the Health Impact Fund. It
seems that there is a gradual spread of NICE-style methodologies in
countries around the world, which have substantial impacts on the
pharmaceutical industry, and which are in many ways similar to the
approach proposed in the Health Impact Fund.

Readers are encouraged to submit comments to the author.

Aidan Hollis
Professor of Economics

University of Calgary, 2500 University Dr NW Calgary AB T2N 1N4 Canada
tel: +1 403 220 5861  fax: +1 403 220 5861
email: ahollis@ucalgary.ca
web: http://econ.ucalgary.ca/hollis.htm

Incentives for Global Health
http://www.healthimpactfund.org